Biotech Late Stage Investors & VC Firms
360 firms in this list, with a median first check of $1M. 82 of them lead rounds. Generated from verified public data and updated continuously.
Laval Innov
LavalPre-Seed–Late Stage
Teewinot Ventures
Pre-Seed–Late Stage
Oceanpine Capital
BeijingSeries A–Late Stage
5 people
Zhejiang Sino Wisdom Investment Co.,Ltd.
HangzhouSeries A–Late Stage
5 people
Longbow Capital LLP
NorwichSeries C–Late Stage$1.3M – $12.7M
2 people
Vincera Capital
TaipeiSeed–Late Stage$500K – $10M
2 people
Kenson Ventures, LLC
Menlo ParkSeed–Late Stage$500K – $3M
1 person
Augere Venture
KrakówSeed–Late Stage
2 people
CIBC
TorontoPre-Seed–Late Stage
1 person
SL Investment Ltd.
SeoulSeries A–Late Stage$500K – $2M
West Virginia Jobs Investment Trust
CharlestonSeed–Late Stage$100K – $1M
Capricornio Capital
Growth–Late Stage$1M – $10M
CBC Group
SingaporeSeed–Late Stage
2 people
INCJ, Ltd.
TokyoSeed–Late Stage
1 person
JAIC
Palo AltoSeed–Late Stage
Malaysia Debt Ventures Bhd.
Kuala LumpurSeed–Late Stage
2 people
Healthequity
BarcelonaSeed–Late Stage
1 person
RecapHealth Ventures
VancouverSeed–Late Stage
1 person
Ilshin Investment Co. Ltd.
SeoulSeed–Late Stage
1 person
3H Health Investment
ShanghaiSeries A–Late Stage
SDIC Venture Capital
BeijingSeed–Late Stage
Imperial Capital Group Ltd
TorontoGrowth–Late Stage
Peloton Capital Management
Toronto, OntarioGrowth–Late Stage
Persistence Capital Partners
MontrealGrowth–Late Stage
Related lists
Biotech Investors & VC Firms (2585)Biotech Seed Investors & VC Firms (2105)Late Stage Investors & VC Firms (1710)Biotech Series A Investors & VC Firms (1693)Biotech Investors & VC Firms in North America (1688)Biotech Investors & VC Firms in United States (1535)Biotech Investors & VC Firms in Europe (990)Biotech Pre-Seed Investors & VC Firms (987)Late Stage Investors & VC Firms in North America (915)Biotech Investors & VC Firms in Global (887)
Data sourced from public filings and firms' own websites — see our methodology.






